510(k) Report

510(k) · Cleared

Recalled · 2010

Dimension Exl N-Ternmial Pro-Brain Natriuretic Peptide (NTP) Flex Reagent Cartridge, Model RF623

K082645510(k) SpecialCleared Sep 22, 200811-day reviewClass II21 CFR 862.1117Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics · NBC Test, Natriuretic Peptide

Cleared on Sep 22, 2008 as substantially equivalent to K080578 (Siemens Healthcare Diagnostics, Inc., 2008) after an 11-day review. Its family tree reaches back 5 generations to 2000. It has been recalled once.

Decided
Sep 22, 2008
Review
11 days
Class
Class II
Product code
NBC
Recalls
1
Predicates
1

Its longest line of descent runs back 5 generations to DEN000010 (2000). No later device cites it as a predicate yet.

  1. Root · 5 generations backDEN000010 Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated · 2000
  2. 4 generations backK022516 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2002
  3. 3 generations backK032646 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2003
  4. 2 generations backK061795 Dimension Vista PBNP Flex Reagent Cartridge and CalibratorDade Behring, Inc. · 2006
  5. 1 generation backK080578 Dimension Vista N-Terminal Pro-Brain Natriuretic Peptide (PBNP) Flex…Siemens Healthcare Diagnostics, Inc. · 2008
  6. This deviceK082645 Dimension Exl N-Ternmial Pro-Brain Natriuretic Peptide (NTP) Flex…Siemens Healthcare Diagnostics · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5DEN000010Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated2000—
−4K022516Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2002—
−3K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2003—
−2K061795Dimension Vista PBNP Flex Reagent Cartridge and CalibratorDade Behring, Inc.2006—
−1K080578Dimension Vista N-Terminal Pro-Brain Natriuretic Peptide (PBNP) Flex Reagent…Siemens Healthcare Diagnostics, Inc.2008—
0 (this device)K082645Dimension Exl N-Ternmial Pro-Brain Natriuretic Peptide (NTP) Flex Reagent…Siemens Healthcare Diagnostics2008—
FIG. 1 — Lineage of K082645, 2000–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K080578Dimension Vista N-Terminal Pro-Brain Natriuretic Peptide (PBNP) Flex Reagent Cartridge…
Summary page 1
…n Natriuretic Peptide (NTP) Flex® Reagent Cartridge (RF623) is substantially equivalent to the Dimension Vista® PBNP Flex® reagent cartridge (K6423A) cleared under K080578. G. Device Description: The EXL NTP method is a one-step sandwich chemiluminescent immunoassay based on LOCI® te…
Siemens Healthcare Diagnostics, Inc.2008—

Also cleared against K080578: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 12, 2010Not classifiedZ-0461-2011OtherSome LOCI cartridges have sub-optimal seal of the lidstock that can cause rupture of the package at high elevations, causing the cartridge to leak. Use of leaking cartridges may result in inaccurate test results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 5 companies; a new generation was cleared every 1.7 years on median.
  • None of the 5 ancestors has a recall.
  • 2 other devices also cite its predicate K080578.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

The NTP method is an in vitro diagnostic assay for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human serum and plasma on the Dimension® EXLTM integrated chemistry system with LOCI® Module. In individuals suspected of having congestive heart failure (CHF), measurements of NT-proBNP are used as an aid in the diagnosis and assessment of severity. The test is further indicated for the risk stratification of patients with acute coronary syndrome and heart failure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082645: Dimension Exl N-Ternmial Pro-Brain Natriuretic Peptide (NTP) Flex Reagent Cartridge, Model RF623.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K082645

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026